By targeting LAMB3, the above investigations demonstrated that hsa‐mir‐133a‐2 could inhibit proliferation and invasion of cervical cancer cells, as well as the activation of the PI3K/AKT signaling pathway. Here, AKT1 is linked to cervical cancer.